Physician profile
Thomas A Lalonde
NPI 1497704191
$64,643.08
in general payments reported to CMS, 2019-2025
43 companies · $3,905 in 2025
The $3,905 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $1,838 · 2021: $5,327 · 2022: $14K · 2023: $5,314 · 2024: $4,354 · 2025: $3,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $1,279 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,274.65 |
| Travel and Lodging | $1,278.86 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17,327.13 | 2019-2025 | |
| Medtronic, INC. | $14,241.26 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Micra |
| Abbott Laboratories | $6,852.88 | 2019-2025 | Optis, Thoratec Heartmate 3 Lvas Implant Kit, Pressurewire |
| E.R. Squibb & Sons, L.L.C. | $3,733.13 | 2019-2024 | Eliquis, Camzyos |
| Abiomed | $3,469.14 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $3,091.16 | 2019-2024 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $2,835.78 | 2019-2024 | |
| Medtronic Vascular, INC. | $2,451.39 | 2019-2020 | |
| Amgen INC. | $1,990.83 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $1,180.30 | 2019-2025 | Farapulse, Watchman Flx, Emblem Mri S-Icd |
| Inari Medical, INC. | $971.57 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $897.68 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $670.63 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $607.28 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $508.84 | 2024-2025 | Assure Wcd |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ablative Solutions, INC. | $479.56 | 2021-2022 | |
| Cathworks, INC. | $446.74 | 2022-2023 | Ffrangio |
| Penumbra, INC. | $287.41 | 2023 | Indigo System |
| Bard Peripheral Vascular, INC. | $266.33 | 2019 | |
| Cardiva Medical, INC. | $216.17 | 2022-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Recor Medical INC | $204.30 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Stryker Corporation | $188.46 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Teleflex LLC | $176.70 | 2025 | Guideliner |
| Impulse Dynamics (USA) INC. | $174.38 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.99 | 2021-2025 | Jardiance |
| Siemens Medical Solutions USA, INC. | $159.03 | 2019-2021 | |
| Atricure, INC. | $134.12 | 2021 | |
| Cvrx, INC. | $131.67 | 2021 | |
| Saranas, INC. | $128.77 | 2023 | |
| Ge Healthcare | $114.21 | 2019 | |
| Truvic Medical, INC. | $100.00 | 2022 | |
| Sanofi-Aventis U.S. LLC | $80.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $66.97 | 2019 | |
| Chiesi USA, INC. | $61.28 | 2023-2025 | Kengreal, Cleviprex |
| Novo Nordisk INC | $47.93 | 2024-2025 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $40.69 | 2019 | |
| Merck Sharp & Dohme LLC | $36.67 | 2025 | Verquvo |
| Tactile Systems Technology INC | $24.90 | 2025 | Nimbl, Flexitouch Plus |
| Actelion Pharmaceuticals US, INC. | $24.63 | 2022 | |
| Terumo Medical Corporation | $22.74 | 2019 | |
| Biotronik INC. | $15.34 | 2022 | |
| Cardinal Health 200 LLC | $13.09 | 2019 | |
| Gilead Sciences, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lalonde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.